New Age BIOTECH, Inc. was formed develop, market, and license its patented zinc peptide technology. The company has seen total revenue grow from $2.7 million to an estimated $11.1 million in 200B. Although New Age BIOTECH experienced a net loss of $4.5 million profit of $500,000 is projected in 2008.Through various supply and distribution agreements for the mass retail market, NewAge BIOTECH, Inc., has accelerated its entry into the consumer market.
Business Plan on New Age BIOTECH
